The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds ...

Objective: A patient survey was conducted by questionnaire to evaluate patient acceptance and perceptions of efficacy with zanamivir (Glaxo Wellcome), the first in a new class of neuraminidase ...

Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.

Antiviral medications such as neuraminidase inhibitors, like oseltamivir (Tamiflu) and zanamivir (Relenza), and endonuclease inhibitors, such as baloxavir (Xofluza), are used to alleviate symptoms ...